文献速递间质性肺疾病

纤维化间质性肺病中6分钟步行试验参数的轨迹与预后意义:多中心研究

Trajectories and Prognostic Significance of 6-Minute Walk Test Parameters in Fibrotic Interstitial Lung Disease: A Multicenter Study.
PubMed 文献 · Chest · 2022-09-08

该多中心前瞻性注册研究评估纤维化间质性肺病患者6分钟步行试验参数的纵向变化及预后意义,并探索氧合状态变化作为疾病进展生理标准。结果显示IPF/PPF与非IPF/PPF患者功能能力下降相似,PPF标准时点运动或静息低氧血症与无移植生存期降低独立相关,新增低氧血症标准可缩短PPF中位发生时间。

要点

  • IPF/PPF与非IPF/PPF患者6MWD及复合指数年化下降相似。
  • 达到PPF标准时运动或静息低氧血症与无移植生存期降低独立相关。
  • 新增低氧血症标准使IPF和非IPF的PPF中位时间分别缩短至6.7和5.6个月。

核心结论

  • IPF/PPF与非IPF/PPF患者功能能力恶化程度相当。
  • 氧合状态提供PPF预后信息,可能有助于定义纤维化ILD疾病进展。

研究设计与样本

  • 基于澳大利亚和加拿大前瞻性注册登记的多中心研究。
  • 纳入IPF和非IPF纤维化ILD患者,按是否符合进展性肺纤维化(PPF)标准分层。

主要发现

  • IPF/PPF(n=126)和非IPF/PPF(n=227)的运动性低氧血症累积发生率及6MWD和复合指数年化下降相似,且随各PPF标准而异。
  • IPF/非PPF(n=231)和非IPF/非PPF(n=531)的低氧血症发生率显著低于IPF/PPF,非IPF/非PPF组6MWD和复合指数年化增加。
  • 达到PPF标准时运动或静息低氧血症与IPF和非IPF无移植生存期降低独立相关(校正人口学和肺功能)。
  • 新增运动或静息低氧血症作为生理标准后,最终符合两种定义的患者中,IPF的PPF中位时间从11.2个月降至6.7个月,非IPF从11.7个月降至5.6个月(均P < .001)。

关键数值与推荐

  • IPF/PPF(n=126)和非IPF/PPF(n=227)的运动性低氧血症累积发生率和6MWD年化下降相似。
  • IPF/非PPF(n=231)和非IPF/非PPF(n=531)的低氧血症发生率显著低于IPF/PPF。
  • 非IPF/非PPF组6MWD和复合指数年化增加。
  • 新增低氧血症标准使PPF中位时间在IPF从11.2降至6.7个月,非IPF从11.7降至5.6个月(P < .001)。

临床怎么用

  • 在纤维化ILD患者中监测6MWT参数及氧合状态有助于评估功能能力变化。
  • 达到PPF标准时出现运动或静息低氧血症提示无移植生存期较差。
  • 考虑将新发运动或静息低氧血症纳入PPF生理标准以早期识别疾病进展。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Functional capacity, as measured by the 6-min walk test (6MWT), is often reduced in fibrotic interstitial lung disease (ILD). This study evaluated longitudinal changes and the prognostic significance of 6MWT parameters, and explored change in oxygenation status as a physiological criterion to define disease progression in patients with fibrotic ILD. RESEARCH QUESTIONS: What are the trajectories and prognostic value of 6MWT parameters in patients with fibrotic ILD? STUDY DESIGN AND METHODS: Using prospective registries in Australia and Canada, patients with idiopathic pulmonary fibrosis (IPF) and non-IPF fibrotic ILD were stratified by the presence of criteria for progressive pulmonary fibrosis (PPF). The cumulative incidence of exertional and resting hypoxemia and changes in 6-min walk distance (6MWD) and composite indices (distance-saturation product and distance-saturation-oxygen product) were determined, with prognostic significance evaluated at the time of meeting criteria for PPF. New-onset exertional or resting hypoxemia was evaluated as another potential criterion for PPF. RESULTS: Patients with IPF/PPF (n = 126) and non-IPF/PPF (n = 227) had a similar cumulative incidence of exertional hypoxemia and annualized decline in 6MWD and composite indices, which varied across each PPF criterion. Patients with IPF/non-PPF (n = 231) and non-IPF/non-PPF (n = 531) had a significantly lower incidence of hypoxemia than those with IPF/PPF, with an annualized increase in 6MWD and composite indices in the non-IPF/non-PPF group. Exertional or resting hypoxemia at the time of meeting criteria for PPF was independently associated with reduced transplant-free survival in IPF and non-IPF, adjusting for patient demographics and lung function. Adding new-onset exertional or resting hypoxemia as a physiological criterion reduced the median time to development of PPF from 11.2 to 6.7 months in IPF and from 11.7 to 5.6 months in non-IPF in patients who eventually met both definitions (P < .001 for both). INTERPRETATION: Patients with IPF/PPF and non-IPF/PPF have comparable deterioration in functional capacity. Oxygenation status provides prognostic information in PPF and may assist in defining disease progression in fibrotic ILD.

来源:Chest,查看原文。版权归原作者所有。

引用

  1. Khor YH, Farooqi M, Hambly N, et al. Trajectories and Prognostic Significance of 6-Minute Walk Test Parameters in Fibrotic Interstitial Lung Disease: A Multicenter Study. Chest. 2022. PMID: 36089070. doi:10.1016/j.chest.2022.08.2233

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。